[Epidemiologic evidence in the treatment of cardiovascular risk factors in Germany].

Up to now, approaches neither in primary nor in secondary prevention led to a relevant decline in prevalences of hypertension and hypercholesterolemia. On the contrary, prevalence of hypercholesterolemia increased from 38 to 40% (p < 0.001) while the hypertension prevalence stagnated (at nearly 20%) in the 30 to 69 years old population in West Germany between 1984/85 and 1991/92.

[Hip ultrasound screening within the scope of U3--initial experiences].

Objective: After introduction of hip sonographic screening in Germany in the year 1996 we are interested in its organisational features and the results on a national level. It has to be scrutinized in how far the medical consequences are oriented and in accordance with the national guideline of hip sonographic screening.

Methods: Our study includes all 191.

[Cost-effectiveness of conservative therapy of knee joint osteoarthritis].

Unlabelled: Hyaluronic acid (HYA) recently in several clinical studies has been shown to reduce gonarthrotic pain and to improve mobility. As an outcome measure usually the medical judgement and/or patient satisfaction as well as the Lequesne-index or the Euroquol index were used. The objective of this study was to investigate the cost-effectiveness (CEA) of HYA in a German ambulatory setting.

Economic evaluation of lenograstim (glycosylated rHuG-CSF) in the treatment of inflammatory breast cancer for Germany and Italy.

Data from a French placebo-controlled double-blind trial in 120 female patients treated with high dose fluorouracil, epirubicin and cyclophosphamide (HD-FEC) chemotherapy for inflammatory breast cancer were used to assess the economic impact of adjunctive lenograstim therapy. The analysis compared direct costs of treatment, with or without lenograstim, with reference to the Social Security (Germany) or to the National Health Service (Italy). Resource utilisation differed between the 2 treatment groups.